Patents

AVEO Oncology has exclusive rights and proprietorship of the following:

FOTIVDA^® (tivozanib hydrochloride)

This product, the process of its manufacture, or its use, may be covered by one or more U.S. Patents, including U.S. Patent Nos. 6,821,987, 7,166,722, and 11,504,365. Additional patents may be issued and/or pending. This page is intended to serve as notice of patent coverage of products under 35 U.S.C. § 287(a).

As used in this Virtual Patent Marking, the name “AVEO Pharmaceuticals, Inc.” includes AVEO Pharmaceuticals, Inc., an LG Chem company and AVEO Oncology, an LG Chem company.

Label

FOTIVDA^® (tivozanib hydrochloride)

Manufactured for:

AVEO Pharmaceuticals, Inc., an LG Chem company
Boston, MA 02210

Manufactured by:

Catalent CTS, Inc.
Kansas City, MO 64137
Made in Japan
© 2024 AVEO Pharmaceuticals, Inc. All rights reserved.